ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for pro Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
Apellis Pharmaceuticals Inc

Apellis Pharmaceuticals Inc (APLS)

38.42
0.35
(0.92%)
At close: 25 June 6:00AM
38.42
0.00
( 0.00% )
After Hours: 6:32AM

Income Statement

Balance Sheet

Cash Flow

Quarter End Jun 2022Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024
USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)
Total Revenue 16.32M22.06M22.66M44.85M94.97M110.4M146.38M172.33M
Operating Income -148.62M-152.94M-164.05M-175.08M-120.44M-137.08M-84.52M-62.09M
Pre Tax Income -155.49M-190.82M-167.46M-177.5M-121.84M-140M-84.15M-66.25M
Net Income -155.98M-191.27M-165.99M-177.78M-122.04M-140.24M-85.58M-66.42M
Preferred Dividends 00000000
Basic Earnings Per Share (EPS) 00000000
EBIT -148.48M-152.84M-164.3M-175.36M-120.51M-137.68M-84.3M-62.59M
EBITDA -148.24M-152.54M-163.67M-174.66M-120.02M-136.62M-84.04M-61.65M
Year End 31 December 2023 20162017201820192020202120222023
USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)
Total Revenue 0000250.65M66.56M75.42M396.59M
Operating Income -27.28M-50.77M-127.93M-288.02M-213.73M-536.28M-594.61M-517.12M
Pre Tax Income -27.13M-51.01M-127.5M-304.71M-343.03M-746M-651.5M-523.5M
Net Income -27.13M-51.01M-127.5M-304.71M-344.87M-746.35M-652.17M-525.63M
Preferred Dividends 00000000
Basic Earnings Per Share (EPS) -1.509-1.013-2.266-5.414-4.53-7.653-5.888-4.436
EBIT -27.13M-50.76M-128.04M-289.69M-214.23M-534.92M-594.9M-517.85M
EBITDA -27.28M-50.77M-127.93M-287.78M-213.09M-534.9M-593.06M-515.34M

Your Recent History

Delayed Upgrade Clock